TP53 and posterior cortical atrophy: To dissect the molecular mechanism how recruited mast cells could alter PCa chemotherapy sensitivity, we focused on the p38-p53-p21 signals since early studies indicated that they might play key roles in altering chemotherapy sensitivity [19].